Capricor Therapeutics reported $202.25M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Bioline Rx USD 16.35M 5.23M Jun/2026
Capricor Therapeutics USD 202.25M 39.88M Sep/2026
Cipla INR 250.61B 9.14B Sep/2026
Cytokinetics USD 1.19B 21.34M Sep/2026
Geron USD 468.74M 17.6M Sep/2026
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 135.09M 22.75M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Prothena USD 273.86M 18.15M Sep/2026
PTC Therapeutics USD 2.54B 79.58M Sep/2026
Sarepta Therapeutics USD 2.27B 49.06M Sep/2026